CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system

Alexander Mildner, Matthias MacK, Hauke Schmidt, Wolfgang Brück, Marija Djukic, Mark D. Zabel, Andrea Hille, Josef Priller, Marco Prinz

Research output: Contribution to journalArticlepeer-review

361 Scopus citations


The chemokine receptor CCR2 plays a vital role for the induction of autoimmunity in the central nervous system. However, it remains unclear how the pathogenic response is mediated by CCR2-bearing cells. By combining bone marrow chimerism with gene targeting we detected a mild disease-modulating role of CCR2 during experimental autoimmune encephalomyelitis, a model for central nervous system autoimmunity, on radio-resistant cells that was independent from targeted CCR2 expression on endothelia. Interestingly, absence of CCR2 on lymphocytes did not influence autoimmune demyelination. In contrast, engagement of CCR2 on accessory cells was required for experimental autoimmune encephalomyelitis induction. CCR2+Ly-6Chi monocytes were rapidly recruited to the inflamed central nervous system and were crucial for the effector phase of disease. Selective depletion of this specific monocyte subpopulation through engagement of CCR2 strongly reduced central nervous system autoimmunity. Collectively, these data indicate a disease-promoting role of CCR2 +Ly-6Chi monocytes during autoimmune inflammation of the central nervous system.

Original languageEnglish
Pages (from-to)2487-2500
Number of pages14
Issue number9
StatePublished - Sep 2009
Externally publishedYes


  • Autoimmune encephalitis
  • Chemokines
  • Monocytes
  • Multiple sclerosis


Dive into the research topics of 'CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system'. Together they form a unique fingerprint.

Cite this